Bangkok Dusit Medical Services (BDMS) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
4 Aug, 2026Company overview and scale
Largest private health-tech service provider in Thailand with estimated THB 7.3 billion revenue in 2026.
Operates 100+ branches across Thailand, Cambodia, Myanmar, and Singapore, serving over 10,000 institutional and 1,000,000 direct-to-consumer customers.
Employs 3,000+ skilled professionals, including multidisciplinary teams of medical and technical experts.
25-year expansion track record with a CAGR of 20.3% from 2002 to 2026E.
Integrated healthcare services
Provides integrated diagnostic services with THB 5 billion projected revenue in 2026 and a 40% market share in Thailand's commercial lab sector.
Conducts over 40 million tests annually for 15 million patients, offering 3,500+ test profiles across multiple specialties.
Accredited by international and national organizations, ensuring high-quality standards.
Offers homecare and mobile wellness services, including blood collection at home by professionals.
Regional expansion and partnerships
Expanded into Myanmar, Cambodia, and Singapore, leveraging local partnerships and scalable models.
Established clinical validation and research hubs in Thailand, Singapore, and China.
Collaborates with leading institutions and companies for genomics, diagnostics, and precision oncology.
Latest events from Bangkok Dusit Medical Services
- Operating income and revenue rose slightly, but net profit fell on higher depreciation and expenses.BDMS
Q2 2026 - Flat operating income and hospital revenue, with a THB 1 per share dividend approved.BDMS
Q1 2026 - 2025 saw 4% YoY growth in operating income and hospital revenue, led by international patient gains.BDMS
Q4 2025 - Net profit rose to ฿12.16 billion on higher revenue, international growth, and network expansion.BDMS
Q3 2025 - Revenue and profit grew 5–6% YoY, led by international patients and strong hospital operations.BDMS
Q2 2025 - 9M24 net profit rose 12% to ฿11.65 billion on revenue of ฿81.6 billion, driven by patient growth.BDMS
Q3 2024 - Net profit rose 14% in H1 2024, driven by hospital growth and international patient revenue.BDMS
Q2 2024 - Net profit rose over 6% YoY, supported by international and upcountry hospital growth.BDMS
Q1 2025 - 2024 saw double-digit net profit growth, strong international patient demand, and major expansion projects.BDMS
Q4 2024